Literature DB >> 8880374

Preliminary evidence that daily changes in frontal alpha asymmetry correlate with changes in affect in therapy sessions.

J P Rosenfeld1, E Baehr, R Baehr, I H Gotlib, C Ranganath.   

Abstract

Frontal EEG alpha asymmetry was recorded from five depressed outpatients during early EEG biofeedback sessions. Mood was assessed prior to and after each session, and affect change scores were also derived by subtracting pre-session from post-session scores. Alpha magnitude was obtained via Fast Fourier Transforms. All scores (EEG alpha asymmetry and affect) were converted to deviation scores by subtracting each patient's daily score from that patient's mean across all available sessions for that patient. Pearson correlations were then computed between asymmetry and affect scores using the deviation scores combined over patients. There was little evidence of correlation between day-to-day asymmetry score and any single affect score. Strong correlations were obtained, however, between asymmetry score and affect change score and, in particular, between asymmetry score and change in positive affect.

Entities:  

Mesh:

Year:  1996        PMID: 8880374     DOI: 10.1016/0167-8760(96)00037-2

Source DB:  PubMed          Journal:  Int J Psychophysiol        ISSN: 0167-8760            Impact factor:   2.997


  10 in total

1.  Frontal alpha EEG asymmetry before and after behavioral activation treatment for depression.

Authors:  Jackie K Gollan; Denada Hoxha; Dietta Chihade; Mark E Pflieger; Laina Rosebrock; John Cacioppo
Journal:  Biol Psychol       Date:  2014-03-24       Impact factor: 3.251

2.  Modulation of subgenual anterior cingulate cortex activity with real-time neurofeedback.

Authors:  J Paul Hamilton; Gary H Glover; Jung-Jiin Hsu; Rebecca F Johnson; Ian H Gotlib
Journal:  Hum Brain Mapp       Date:  2011-01       Impact factor: 5.038

3.  Top-down and bottom-up mechanisms in mind-body medicine: development of an integrative framework for psychophysiological research.

Authors:  Ann Gill Taylor; Lisa E Goehler; Daniel I Galper; Kim E Innes; Cheryl Bourguignon
Journal:  Explore (NY)       Date:  2010 Jan-Feb       Impact factor: 1.775

4.  Frontal Alpha Asymmetry in Posttraumatic Stress Disorder: Group Differences Among Individuals With and Without PTSD During an Inhibitory Control Task.

Authors:  Teresa López-Castro; Laura Martin; Sean Nickley; Tanya C Saraiya; Robert D Melara
Journal:  Clin EEG Neurosci       Date:  2021-10-16       Impact factor: 2.046

5.  Electroacupuncture plus moxibustion for major depressive disorder: A randomized, sham-controlled, pilot clinical trial.

Authors:  Mikyung Kim; Eun-Ji Choi; O-Jin Kwon; Hyo-Ju Park; Ae-Ran Kim; Bok-Nam Seo; Sun-Yong Chung; Jun-Hwan Lee; Joo-Hee Kim
Journal:  Integr Med Res       Date:  2021-11-03

6.  Electroacupuncture plus moxibustion for major depressive disorder: A randomized, sham-controlled, pilot clinical trial.

Authors:  Mikyung Kim; Eun-Ji Choi; O-Jin Kwon; Hyo-Ju Park; Ae-Ran Kim; Bok-Nam Seo; Sun-Yong Chung; Jun-Hwan Lee; Joo-Hee Kim
Journal:  Integr Med Res       Date:  2021-04-23

7.  An open label study of the use of EEG biofeedback using beta training to reduce anxiety for patients with cardiac events.

Authors:  Anne John Michael; Saroja Krishnaswamy; Jamaludin Mohamed
Journal:  Neuropsychiatr Dis Treat       Date:  2005-12       Impact factor: 2.570

8.  Neurofeedback as a treatment for major depressive disorder--a pilot study.

Authors:  Frenk Peeters; Mare Oehlen; Jacco Ronner; Jim van Os; Richel Lousberg
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

Review 9.  Neurofeedback and networks of depression.

Authors:  David E J Linden
Journal:  Dialogues Clin Neurosci       Date:  2014-03       Impact factor: 5.986

10.  Neurophysiologic Correlates of Post-stroke Mood and Emotional Control.

Authors:  Deniz Doruk; Marcel Simis; Marta Imamura; André R Brunoni; Leon Morales-Quezada; Renato Anghinah; Felipe Fregni; Linamara R Battistella
Journal:  Front Hum Neurosci       Date:  2016-08-30       Impact factor: 3.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.